Ziad Ali, MD
Internal Medicine · New York, NYNPI 1588844245
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Shockwave Medical, Inc at 54.6% of the total. 2025 is the largest year on record at $786,838, 7.2 times the $109,761 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,307 payments — averaging $1554.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$1.1M
- Philips North America LLC$187K
- Abbott$179K
- AstraZeneca$152K
- Boston Scientific$151K
- Acist Medical Systems, Inc.$86K
- plus $168K from 25 others
Across 33 payments — averaging $29,146 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$427K
- Shockwave Medical, Inc$238K
- Edwards Lifesciences$128K
- Heartflow, Inc.$80K
- Novartis$66K
- Boston Scientific$22K
Across 4 payments — averaging $64,737 each. An ownership or investment interest held by the physician or an immediate family member.
- Spectrawave, Inc$259K
- Shockwave Medical, Inc$0
What the payments were for
- Consulting fees$958,30047%
- Speaking & faculty fees$573,62528%
- Grants$5000%
- Travel & lodging$451,14022%
- Food & beverage$45,5622%
- Education$2,6000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 413 | $1,108,881 |
| Philips North America LLC | 96 | $186,541 |
| Abbott | 298 | $178,975 |
| AstraZeneca | 137 | $152,285 |
| Boston Scientific | 131 | $150,666 |
| Acist Medical Systems, Inc. | 37 | $86,321 |
| Abiomed | 45 | $47,197 |
| Heartflow, Inc. | 17 | $42,810 |
| Amgen | 12 | $20,616 |
| Spectrawave, Inc | 10 | $16,175 |
| Opsens Inc. | 7 | $14,380 |
| Cathworks, Inc. | 10 | $13,980 |
| Medtronic(2 entities) | 36 | $3,748 |
| Siemens Medical Solutions USA, Inc. | 1 | $3,500 |
| Edwards Lifesciences | 34 | $3,168 |
| Terumo Medical Corporation | 1 | $550 |
| Biotronik Inc. | 4 | $351 |
| Fresenius USA Marketing, Inc. | 1 | $249 |
| Cardiovascular Systems Inc. | 4 | $248 |
| Neovasc Medical Inc | 1 | $210 |
| Recor Medical Inc | 1 | $157 |
| Asahi Intecc USA, Inc. | 1 | $146 |
| ZOLL Circulation Inc | 1 | $130 |
| Arrow International, Inc. | 1 | $118 |
| Angiodynamics, Inc. | 2 | $109 |
| W. L. Gore & Associates, Inc. | 1 | $89 |
| Artivion, Inc. | 1 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| GE HealthCare | 1 | $23 |
| Merck | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,065,929
- (9520) IGT Devices Undivided$179,868
- BRILINTA$126,741
- GENERAL VASCULAR ACCESS$80,141
- OPTIS$73,757
- Xience V coronary stent system$59,828
- ISOVUE$56,984
- Impella$46,756
- FFRct$42,567
- Vascular Lithotripsy$41,034
- COROFLOW$28,542
- EMPOWER CTA$26,550
- Repatha$20,520
- HyperVue Imaging System$16,002
- OPTICROSS$14,240
- OptoWire$14,200
- FFRangio$13,888
- GENERAL - THERAPIES$9,078
- FARXIGA$8,810
- Starlight Imaging Catheter$6,002
How this compares
$2,031,727 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
- Louis AronneNew York$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.